Urban-Related Environmental Exposures during Pregnancy and Placental Development and Preeclampsia: a Review.


Journal

Current hypertension reports
ISSN: 1534-3111
Titre abrégé: Curr Hypertens Rep
Pays: United States
ID NLM: 100888982

Informations de publication

Date de publication:
03 09 2020
Historique:
entrez: 4 9 2020
pubmed: 4 9 2020
medline: 12 3 2021
Statut: epublish

Résumé

To summarize the current knowledge of the pathophysiological implications and the clinical role of urban-related environmental exposures in pregnancy. The ongoing urbanization worldwide is leading to an increasing number of pregnant women being exposed to higher levels of urban-related environmental hazards such as air pollution and noise and, at the same time, having less contact with natural environments. Pregnancy represents a particular and vulnerable life period both for women and their children. Extensive physiological and metabolic changes, as well as changes to the cardiovascular and respiratory systems during pregnancy, could result in increased sensitivity to damage by environmental factors. Exposure to air pollution and noise is associated with placental dysfunction and damage, which, in turn, could lead to maternal complications such as preeclampsia. In contrast, more contact with greenspace during pregnancy seems to mitigate these adverse impacts. These findings open up new challenges for our understanding of the potential effect of urban living on placental function and preeclampsia, and offer new clinical and research opportunities.

Identifiants

pubmed: 32880755
doi: 10.1007/s11906-020-01088-4
pii: 10.1007/s11906-020-01088-4
doi:

Substances chimiques

Air Pollutants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

81

Auteurs

María Julia Zanini (MJ)

Obstetrics and Gynecology Department, High Risk Unit, Sant Pau University Hospital, C/Sant Quintí, 89, 08041, Barcelona, Spain.
Women and Perinatal Health Research Group, Biomedical Research Institute Sant Pau (IIB-SantPau), Sant Pau University Hospital, Barcelona, Spain.
School of Medicine, UniversitatAutònoma de Barcelona, Barcelona, Spain.

Carla Domínguez (C)

Obstetrics and Gynecology Department, High Risk Unit, Sant Pau University Hospital, C/Sant Quintí, 89, 08041, Barcelona, Spain.
Women and Perinatal Health Research Group, Biomedical Research Institute Sant Pau (IIB-SantPau), Sant Pau University Hospital, Barcelona, Spain.
School of Medicine, UniversitatAutònoma de Barcelona, Barcelona, Spain.

Toni Fernández-Oliva (T)

Obstetrics and Gynecology Department, High Risk Unit, Sant Pau University Hospital, C/Sant Quintí, 89, 08041, Barcelona, Spain.
Women and Perinatal Health Research Group, Biomedical Research Institute Sant Pau (IIB-SantPau), Sant Pau University Hospital, Barcelona, Spain.
School of Medicine, UniversitatAutònoma de Barcelona, Barcelona, Spain.

Olga Sánchez (O)

Obstetrics and Gynecology Department, High Risk Unit, Sant Pau University Hospital, C/Sant Quintí, 89, 08041, Barcelona, Spain.
Women and Perinatal Health Research Group, Biomedical Research Institute Sant Pau (IIB-SantPau), Sant Pau University Hospital, Barcelona, Spain.
School of Medicine, UniversitatAutònoma de Barcelona, Barcelona, Spain.
Maternal and Child Health and Development Network (SAMID), RD16/0022/0015, Instituto de Salud Carlos III, Barcelona, Spain.

María Torres Toda (MT)

ISGlobal, 08003, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), 08002, Barcelona, Spain.
CIBER Epidemiología y SaludPública (CIBERESO), 28029, Madrid, Spain.

María Foraster (M)

ISGlobal, 08003, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), 08002, Barcelona, Spain.
CIBER Epidemiología y SaludPública (CIBERESO), 28029, Madrid, Spain.

Payam Dadvand (P)

ISGlobal, 08003, Barcelona, Spain.
Universitat Pompeu Fabra (UPF), 08002, Barcelona, Spain.
CIBER Epidemiología y SaludPública (CIBERESO), 28029, Madrid, Spain.

Elisa Llurba (E)

Obstetrics and Gynecology Department, High Risk Unit, Sant Pau University Hospital, C/Sant Quintí, 89, 08041, Barcelona, Spain. ellurba@santpau.cat.
Women and Perinatal Health Research Group, Biomedical Research Institute Sant Pau (IIB-SantPau), Sant Pau University Hospital, Barcelona, Spain. ellurba@santpau.cat.
School of Medicine, UniversitatAutònoma de Barcelona, Barcelona, Spain. ellurba@santpau.cat.
Maternal and Child Health and Development Network (SAMID), RD16/0022/0015, Instituto de Salud Carlos III, Barcelona, Spain. ellurba@santpau.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH